• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-G; IGG ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-G; IGG ANTI-HAV Back to Search Results
Catalog Number 06C29-27
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Evaluation of the customer issue included a complaint text review, a search for similar complaints, device history review, labeling review, specificity testing, and field data review.The product was not returned.No adverse trend was identified for the customer issue.Device history review did not identify any issues that may have caused the customer issue.Labeling was reviewed and found to be adequate.No patient sample was available for return, therefore clinical specificity testing of negative control replicates was performed using in-house retained kits stored at the recommended storage condition.Specificity testing met all specifications.Abbott link world wide data was used to evaluate historical product field performance.Patient data was analyzed the evaluation indicated that the patient median result for the complaint material was comparable to other lots in the field between november 19, 2018 and november 17, 2018.Negative population data was analyzed, and the complaint lot results were within the established limits.No unusual reagent lot performance was identified.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified, and no product deficiency was found.This report is being filed on an international product, list number 6c29 that has a similar product distributed in the us, list number 6c27.Note, issue was already reported for lot 86040li00 under mfr report 3002809144-2018-00484.
 
Event Description
The customer observed falsely elevated igg antibody to (b)(6) (igg anti-hav) results while using architect havab-igg reagents.The following data was provided.Sid (b)(6): v4251 repeat using lot 80173li00 (b)(6), using lot 86040li00 initial (b)(6), repeat (b)(6).No adverse impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-G
Type of Device
IGG ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key8201478
MDR Text Key132567435
Report Number3002809144-2018-00560
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Reporter Country CodeSN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/22/2018
Device Catalogue Number06C29-27
Device Lot Number80173LI00
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/07/2018
Initial Date FDA Received12/27/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/23/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-